Eficacia y costo-utilidad de primer reemplazo total de cadera y rodilla en pacientes con osteoartritis
Resumen
Objetivo: determinar la eficacia, costos y razón incremental de costo-utilidad (RICU) de la cirugía de primer reemplazo total de rodilla y cadera en pacientes con osteoartritis.Citas
I. Becker R, Döring C, Denecke A, Brosz M. Expectation, satisfaction and clinical outcome of patients after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2011;19(9):1433-1441.
II. Fortin PR, Clarke AE, Joseph L, et al. Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum. 1999;42(8):1722-1728.
III. Russo A, Elixhauser A, Steiner C, Wier L. Hospital-Based Ambulatory Surgery, 2007. HEALTHCARE COST UTILIZATION PROJECT. 2010.
IV. HCaU P. HCUP Facts and Figures: Statistics on Hospital-Based Care in the United States, 2009. Healthcare Cost and Utilization Project. 2009.
V. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780-785.
VI. Losina E, Walensky RP, Kessler CL, et al. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med. 2009;169(12):1113-1121; discussion 1121-1112.
VII. Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, et al. Cost-effectiveness of total knee replacement: a prospective cohort study. Arthritis Care Res (Hoboken). 2014;66(4):592-599.
VIII. Lopreite F, Garabano G, Harold S. Reemplazo total de cadera bilateral en un tiempo. Rev Asoc Argent Ortop Traumatol. 2011;76:146-151.
IX. Mana Pastrián D, Garabano G, Nazur G, Pesciallo C, Vedoya S, Viale G. Reemplazo total de rodilla bilateral: Análisis de costos entre uno y dos tiempos. . Rev Asoc Argent Ortop Traumatol. 2010;75(2):151-156.
X. Plans IFoH. 2012 Comparative Price Report. Variation in Medical and Hospital Prices by Country 2012. Accessed 20 de Mayo, 2016.
XI. C harlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
XII. Augustovski FA, Irazola VE, Velazquez AP, Gibbons L, Craig BM. Argentine valuation of the EQ-5D health states. Value Health. 2009;12(4):587-596.
XIII. Knee Injury and Osteoarthritis outcome. Accessed 20 de Mayo, 2016.
XIV. H ealth NI. Patient Reported Outcomes Measurement Information System (PROMIS). Accessed 22 Mayo, 2016.
XV. Drummond M, Sculpher M, Torrance G. Methods for the economic evaluation of health care programmes. Oxford University Press; 2005.
XVI. AMP. Actualización de los valores de IOMA. 2016. Accessed 22 de Mayo, 2016.
XVII. CADIME. NOMENCLADOR LABORATORIOS DE ANÁLISIS CLÍNICOS. 2016. Accessed 22 de Mayo, 2016.
XVIII. ANMAT. (VNM) Vademecum Nacional de Medicamentos. 2016. Accessed 22 Mayo, 2016.
XIX. R esolución 4/2015. Salario Mínimo, Vital y Móvil. Modificación. 2015. Accessed 22 Mayo, 2016.
XX. Phibbs CS, Luft HS. Correlation of travel time on roads versus straight line distance. Med Care Res Rev. 1995;52(4):532-542.
XXI. CPIA. Costo por Kilómetro de un Automóvil Mediano para Uso Profesional a Febrero de 2016. 2016. Accessed 22 de Mayo, 2016.
XXII. ASSOCIATES R. Work Productivity and Activity Impairment Questionnaire (WPAI). 2016. Accessed 22 Mayo, 2016.
XXIII. Ackerman IN, Bennell KL, Osborne RH. Decline in Health-Related Quality of Life reported by more than half of those waiting for joint replacement surgery: a prospective cohort study. BMC Musculoskelet Disord. 2011;12:108.
XXIV. Desmeules F, Dionne CE, Belzile E, Bourbonnais R, Frémont P. The burden of wait for knee replacement surgery: effects on pain, function and health-related quality of life at the time of surgery. Rheumatology (Oxford). 2010;49(5):945-954
XXV. McHugh GA, Luker KA, Campbell M, Kay PR, Silman AJ. Pain, physical functioning and quality of life of individuals awaiting total joint replacement: a longitudinal study. J Eval Clin Pract. 2008;14(1):19-26.
XXVI. F MI. World Economic and Financial Surveys. World Economic Outlook Database. 2016. Accessed 22 Mayo, 2016.
XXVII. Escobar A, Quintana JM, Bilbao A, Aróstegui I, Lafuente I, Vidaurreta I. Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. Osteoarthritis Cartilage. 2007;15(3):273-280.
Derechos de autor 2017 Sociedad Argentina de Reumatología
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.